12,386
Participants
Start Date
May 31, 2010
Primary Completion Date
January 31, 2011
Study Completion Date
January 31, 2011
Anti-epileptic drug (AED)
Prescription claim for at least one AED including lamotrigine, tiagabine, pregabalin, ethosuximide, lacosamide, phenytoin, carbamazepine, valproic acid, felbamate, levetiracetam, zonisamide, primidone, oxcarbazepine, vigabatrin, phenobarbital, gabapentin, topiramate.
Lead Sponsor
GlaxoSmithKline
INDUSTRY